Cargando…
Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variants
Antibody therapies represent a valuable tool to reduce COVID-19 deaths and hospitalizations. Multiple antibody candidates have been granted emergency use authorization by the Food and Drug Administration and many more are in clinical trials. Most antibody therapies for COVID-19 are engineered to bin...
Autores principales: | Engelhart, Emily, Lopez, Randolph, Emerson, Ryan, Lin, Charles, Shikany, Colleen, Guion, Daniel, Kelley, Mary, Younger, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129155/ https://www.ncbi.nlm.nih.gov/pubmed/35769631 http://dx.doi.org/10.1093/abt/tbac011 |
Ejemplares similares
-
A dataset comprised of binding interactions for 104,972 antibodies against a SARS-CoV-2 peptide
por: Engelhart, Emily, et al.
Publicado: (2022) -
Machine learning optimization of candidate antibody yields highly diverse sub-nanomolar affinity antibody libraries
por: Li, Lin, et al.
Publicado: (2023) -
Multiplex Assessment of Protein Variant Abundance by Massively Parallel Sequencing
por: Matreyek, Kenneth A., et al.
Publicado: (2018) -
Measuring the sequence-affinity landscape of antibodies with massively parallel titration curves
por: Adams, Rhys M, et al.
Publicado: (2016) -
Multiplexed, High-Sensitivity Measurements of Antibody Affinity Using Interferometric Reflectance Imaging Sensor
por: Marn, Allison M., et al.
Publicado: (2021)